CLINICAL_TRIALS
trial_result
· 2017-07-02
Clinical Trial Update: A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease [Phase 2]
Summary
Phase 2 trial to evaluate safety and efficacy of baricitinib in participants with diabetic kidney disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02